טוען...
Nicotine reduces established L-dopa-induced dyskinesias in a monkey model of Parkinson’s disease
BACKGROUND: Although 3,4-dihydroxyphenylalanine (L-dopa) is the gold-standard treatment for Parkinson’s disease, it can lead to disabling dyskinesias. Previous work showed that nicotine reduces L-dopa-induced dyskinesias (LIDs) in several parkinsonian animal models. The goal of this study was to det...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3787977/ https://ncbi.nlm.nih.gov/pubmed/23836409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25594 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|